Armstrong MJ, Okun MS (2020) Diagnosis and treatment of Parkinson disease: a review. Jama 323(6):548–560. https://doi.org/10.1001/jama.2019.22360

Article  PubMed  Google Scholar 

Tysnes OB, Storstein A (2017) Epidemiology of Parkinson’s disease. J Neural Transm (Vienna) 124(8):901–905. https://doi.org/10.1007/s00702-017-1686-y

Article  PubMed  Google Scholar 

Vascellari S, Manzin A (2021) Parkinson’s disease: a prionopathy? Int J Mol Sci 22(15):8022. https://doi.org/10.3390/ijms22158022

Article  PubMed  PubMed Central  CAS  Google Scholar 

Macías-García P et al (2022) Neuropsychiatric symptoms in clinically defined Parkinson’s disease: an updated review of literature. Behav Neurol 2022:1213393. https://doi.org/10.1155/2022/1213393

Article  PubMed  PubMed Central  Google Scholar 

Fasano A et al (2015) Gastrointestinal dysfunction in Parkinson’s disease. Lancet Neurol 14(6):625–39. https://doi.org/10.1016/s1474-4422(15)00007-1

Article  PubMed  CAS  Google Scholar 

Pfeiffer RF (2018) Gastrointestinal dysfunction in Parkinson’s disease. Curr Treat Options Neurol 20(12):54. https://doi.org/10.1007/s11940-018-0539-9

Article  PubMed  Google Scholar 

Bose A, Beal MF (2016) Mitochondrial dysfunction in Parkinson’s disease. J Neurochem 139(Suppl 1):216–231. https://doi.org/10.1111/jnc.13731

Article  PubMed  CAS  Google Scholar 

Chen PC et al (2021) The potential effects of oxidative stress-related plasma abnormal protein aggregate levels on brain volume and its neuropsychiatric consequences in Parkinson’s disease. Oxid Med Cell Longev 2021:3666327. https://doi.org/10.1155/2021/3666327

Article  PubMed  PubMed Central  Google Scholar 

Badanjak K et al (2021) The contribution of microglia to neuroinflammation in Parkinson’s disease. Int J Mol Sci 22(9):4676. https://doi.org/10.3390/ijms22094676

Article  PubMed  PubMed Central  CAS  Google Scholar 

Iovino L, Tremblay ME, Civiero L (2020) Glutamate-induced excitotoxicity in Parkinson’s disease: The role of glial cells. J Pharmacol Sci 144(3):151–164. https://doi.org/10.1016/j.jphs.2020.07.011

Article  PubMed  CAS  Google Scholar 

Fleming SM (2017) Mechanisms of gene-environment interactions in Parkinson’s disease. Curr Environ Health Rep 4(2):192–199. https://doi.org/10.1007/s40572-017-0143-2

Article  PubMed  CAS  Google Scholar 

Caputi V, Giron MC (2018) Microbiome-gut-brain axis and toll-like receptors in Parkinson’s disease. Int J Mol Sci 19(6):1689. https://doi.org/10.3390/ijms19061689

Article  PubMed  PubMed Central  CAS  Google Scholar 

Mayer EA, Tillisch K, Gupta A (2015) Gut/brain axis and the microbiota. J Clin Invest 125(3):926–38. https://doi.org/10.1172/jci76304

Article  PubMed  PubMed Central  Google Scholar 

Sampson TR et al (2016) Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson’s disease. Cell 167(6):1469-1480.e12. https://doi.org/10.1016/j.cell.2016.11.018

Article  PubMed  PubMed Central  CAS  Google Scholar 

Yang X et al (2017) Longitudinal analysis of fecal microbiome and pathologic processes in a rotenone induced mice model of Parkinson’s disease. Front Aging Neurosci 9:441. https://doi.org/10.3389/fnagi.2017.00441

Article  PubMed  CAS  Google Scholar 

Sun MF, Shen YQ (2018) Dysbiosis of gut microbiota and microbial metabolites in Parkinson’s disease. Ageing Res Rev 45:53–61. https://doi.org/10.1016/j.arr.2018.04.004

Article  PubMed  CAS  Google Scholar 

Scheperjans F et al (2015) Gut microbiota are related to Parkinson’s disease and clinical phenotype. Mov Disord 30(3):350–8. https://doi.org/10.1002/mds.26069

Article  PubMed  Google Scholar 

Li F et al (2019) Alteration of the fecal microbiota in North-Eastern Han Chinese population with sporadic Parkinson’s disease. Neurosci Lett 707:134297. https://doi.org/10.1016/j.neulet.2019.134297

Article  PubMed  CAS  Google Scholar 

Unger MM et al (2016) Short chain fatty acids and gut microbiota differ between patients with Parkinson’s disease and age-matched controls. Parkinsonism Relat Disord 32:66–72. https://doi.org/10.1016/j.parkreldis.2016.08.019

Article  PubMed  Google Scholar 

Aho VTE et al (2019) Gut microbiota in Parkinson’s disease: temporal stability and relations to disease progression. EBioMed 44:691–707. https://doi.org/10.1016/j.ebiom.2019.05.064

Article  CAS  Google Scholar 

Bedarf JR et al (2017) Functional implications of microbial and viral gut metagenome changes in early stage L-DOPA-naïve Parkinson’s disease patients. Genome Med 9(1):39. https://doi.org/10.1186/s13073-017-0428-y

Article  PubMed  PubMed Central  CAS  Google Scholar 

Heintz-Buschart A et al (2018) The nasal and gut microbiome in Parkinson’s disease and idiopathic rapid eye movement sleep behavior disorder. Mov Disord 33(1):88–98. https://doi.org/10.1002/mds.27105

Article  PubMed  CAS  Google Scholar 

Vidal-Martinez G et al (2020) A pilot microbiota study in Parkinson’s disease patients versus control subjects, and effects of FTY720 and FTY720-mitoxy therapies in Parkinsonian and multiple system atrophy mouse models. J Parkinsons Dis 10(1):185–192. https://doi.org/10.3233/jpd-191693

Article  PubMed  PubMed Central  CAS  Google Scholar 

Lin CH et al (2019) Altered gut microbiota and inflammatory cytokine responses in patients with Parkinson’s disease. J Neuroinflammation 16(1):129. https://doi.org/10.1186/s12974-019-1528-y

Article  PubMed  PubMed Central  CAS  Google Scholar 

Jo S et al (2022) Oral and gut dysbiosis leads to functional alterations in Parkinson’s disease. NPJ Parkinsons Dis 8(1):87. https://doi.org/10.1038/s41531-022-00351-6

Article  PubMed  PubMed Central  CAS  Google Scholar 

Cirstea MS et al (2020) Microbiota composition and metabolism are associated with gut function in Parkinson’s disease. Mov Disord 35(7):1208–1217. https://doi.org/10.1002/mds.28052

Article  PubMed  CAS  Google Scholar 

Hill-Burns EM et al (2017) Parkinson’s disease and Parkinson’s disease medications have distinct signatures of the gut microbiome. Mov Disord 32(5):739–749. https://doi.org/10.1002/mds.26942

Article  PubMed  PubMed Central  CAS  Google Scholar 

Lin A et al (2018) Gut microbiota in patients with Parkinson’s disease in southern China. Parkinsonism Relat Disord 53:82–88. https://doi.org/10.1016/j.parkreldis.2018.05.007

Article  PubMed  Google Scholar 

Barichella M et al (2019) Unraveling gut microbiota in Parkinson’s disease and atypical parkinsonism. Mov Disord 34(3):396–405. https://doi.org/10.1002/mds.27581

Article  PubMed